Adicet Bio Advances FDA-Approved Autoimmune Therapy Trials
Adicet Bio ( (ACET) ) has provided an update. Adicet Bio has received FDA clearance to expand its investigational new drug ...
H.C. Wainwright Reaffirms Their Hold Rating on Adicet Bio (ACET)
In a report released today, Edward White from H.C. Wainwright reiterated a Hold rating on Adicet Bio (ACET – Research Report). The ...
Adicet Bio Announces FDA Clearance of IND Amendment to Evaluate ADI-001 in Idiopathic Inflammatory Myopathy and Stiff Person Syndrome
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the ...
Is Adicet Bio, Inc. (NASDAQ:ACET) the Best Halal Stock
We recently compiled the list of the 7 Best Halal Stocks To Buy Now (Debt Free) according to the hedge funds using the latest sentiment data. In this article, we are going to take a look at where ...
Business Wire19d
Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimm ...
Business Wire1mon
ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...
Business Insider29d
Truist Financial Issues a Buy Rating on Adicet Bio (ACET)
In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Adicet Bio (ACET – Research Report). The company’s shares closed yesterday at $1.52 ...
Ghana Business News6d
Borrowing not sustainable way of development – Deputy BoG Governor
Afari, the first Governor of the Bank of Ghana (BoG), has called for policies to stimulate savings and investment in the ...
证券之星1mon
加拿大投资银行集团：维持Adicet Bio(ACET.US)评级
加拿大投资银行集团：维持Adicet Bio(ACET.US)评级，由买入调整至买入评级, 目标价由19.00美元调整至8.00美元。 艾切托（ACET.US）公司简介：Adicet Bio Inc是 ...
FDA批准Adicet Bio扩大自身免疫疾病试验范围
加利福尼亚州红木城和马萨诸塞州波士顿 - 临床阶段生物技术公司Adicet Bio, Inc. (NASDAQ: ...
Adicet Bio股票在FDA修改IND申请后维持中性评级
周四，H.C. Wainwright维持对Adicet Bio Inc. (NASDAQ: ACET)股票的中性立场，此前该公司宣布美国食品和药物管理局(FDA)同意修改其新药研究申请(IND)。这项修改将允许Adicet Bio在其正在进行的1期试验中评估其药物候选ADI-001对其他自身免疫性疾病的治疗效果。 Adicet Bio的同种异体γδ T细胞产品候选ADI-001包含一个抗CD20 ...